Access to treatment across Europe is extremely variable. Patient advocacy groups can make a huge difference in improving access, but often don’t have the evidence, knowledge and tools to advocate effectively. The European Atlas of Access to Myeloma Treatment aims to reflect access to myeloma treatment across more than 30 European countries, and help understand those differences by analysing a number of associated variables. Based on these findings MPE’s Atlas Coaching Programme is an opportunity for MPE members to identify priorities, gain the needed skills and build successful advocacy strategies to improve access to myeloma treatments in their countries.
Ananda Plate, CEO of Myeloma Patients Europe, Eric Low, former vicepresident of MPE and Marta Ballester, project coordinator at Avedis Donabedian Research Institute, explain in this video the main objectives of this programme: